Improved Blood Pressure Control with Nifedipine GITS/Valsartan Combination Versus High-Dose Valsartan Monotherapy in Mild-to-Moderate Hypertensive Patients from Asia: Results from the ADVISE Study, a Randomized Trial

Cardiovascular Therapeutics

Volumn 30, Issue 6, 2012, Pages 326-332

  Ke, Yuan Nan ^a   Dong, Yu Gang ^b   Ma, Shu Ping ^c   Yuan, Hong ^d   Ihm, Sang Hyun ^e   Baek, Sang Hong ^f  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c Hebei Provincial Hospital   (China)

^d THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^e The Catholic University of Korea   (South Korea)

^f The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Asia; Blood pressure (BP) control; Hypertension; Nifedipine; Valsartan

Indexed keywords

NIFEDIPINE; VALSARTAN;

ADULT; AGED; ARTICLE; ASIA; BLOOD PRESSURE REGULATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIZZINESS; DRUG MEGADOSE; FACE EDEMA; FEMALE; FLUSHING; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; COMORBIDITY; DRUG COMBINATIONS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; PROSPECTIVE STUDIES; TETRAZOLES; VALINE; YOUNG ADULT;

EID: 84867892839     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/1755-5922.12003     Document Type: Article

References (17)

1. Hypertension in the Asia Pacific region - the problem and the solution. APSH web site. Available at: http://www.apsh.org/webCast.html. Accessed April 3, 2012.
2. Chiang CE, Chen CH. Hypertension in the Asia-Pacific region. J Hum Hypertens 2008;22: 441-443.
3. Ma WJ, Tang JL, Zhang YH, et al. Hypertension prevalence, awareness, treatment, control, and associated factors in adults in southern china. Am J Hypertens 2012;25: 590-596.
4. KNHANES. Korean National Health and Nutrition Examination Survey web site. Available at: http://knhanes.cdc.go.kr/. Accessed March 19, 2012.
5. Zhang XF, Attia J, D'Este C, Ma XY. The relationship between higher blood pressure and ischaemic, haemorrhagic stroke among Chinese and Caucasians: meta-analysis. Eur J Cardiovasc Prev Rehabil 2006;13: 429-437.
6. Kengne AP, Patel A, Barzi F, et al. Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region. J Hypertens 2007;25: 1205-1213.
7. Martiniuk AL, Lee CM, Lawes CM, et al. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens 2007;25: 73-79.
8. Woodward M, Tsukinoki-Murakami R, Murakami Y, et al. The epidemiology of stroke amongst women in the Asia-Pacific region. Womens Health (Lond Engl) 2011;7: 305-317.
9. Mancia G, De BG, Dominiczak A, et al. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25: 1105-1187.
10. Mancia G, Parati G, Bilo G, Choi J, Kilama MO, Ruilope LM. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study. J Hypertens 2011;29: 600-609.
11. Hasebe N, Kikuchi K. Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study. J Hypertens 2005;23: 445-453.
12. European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment of hypertension. London: EMA, 2010. EMA/238/1995/Rev. 3.
13. Huang J, Sun NL, Hao YM, et al. Efficacy and tolerability of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients not adequately controlled with valsartan monotherapy. Clin Exp Hypertens 2011;33: 179-186.
14. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27: 2121-2158.
15. Julius S, Kjeldsen SE, Brunner H, et al. VALUE trial: long-term blood pressure trends in 13, 449 patients with hypertension and high cardiovascular risk. Am J Hypertens 2003;16: 544-548.
16. Weber MA, Julius S, Kjeldsen SE, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet 2004;363: 2049-2051.
17. National Institute for Health and Clinical Excellence (NICE). Guideline CG127. Hypertension: Clinical management of primary hypertension in adults. NICE web site. Available at: http://publications.nice.org.uk/hypertension-cg127/key-priorities-for-implementation. Accessed April 20, 2012.